INVESTMENTS |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| INVESTMENTS | INVESTMENTS The following table provides a reconciliation of investments to the Company’s condensed consolidated balance sheets (amounts in thousands):
(1) Presented within prepaid expenses and other current assets on the condensed consolidated balance sheets. (2) Presented within other assets on the condensed consolidated balance sheets. Investment in Equity Securities In 2022 and 2023, the Company purchased equity securities in KORE Power, Inc. (“KORE”), a U.S. manufacturer of battery cells and modules. These equity securities do not have a readily determinable fair value and are recorded at cost, less any impairment, plus or minus adjustments for observable price changes in orderly transactions for the same or similar securities, with unrealized gains and losses recognized in earnings. The Company did not record any impairment on its investment in KORE during the three months ended September 30, 2026 and during the three and nine months ended September 30, 2025. During the nine months ended September 30, 2026, the Company recorded a $2.0 million impairment related to its investment in KORE equity securities based on updated information received during the period, including KORE’s pending merger transaction and the estimated consideration expected to be available to KORE Class A preferred stockholders. The impairment was recorded in other expense, net, in the condensed consolidated statements of operations and comprehensive loss for the nine months ended September 30, 2026. The cost basis of the KORE equity securities is $15.0 million, and cumulative impairment recorded as of September 30, 2026 and December 31, 2025 was $13.8 million and $11.7 million, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||